March 2016

11th Protein Kinases In Drug Discovery Conference February 29 - March 1, 2016, San Diego, CA ( 8:00 am )

11th Protein Kinases in Drug Discovery Conference February 29 - March 1, 2016, San Diego, CA

We invite you to attend the 11th Protein Kinases in Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA.

Over the past decades, protein kinases have proven to be an important class of drug targets for the pharmaceutical industry. This meeting seeks to create a forum for scientists from both industry and academia to gather and discuss the most recent advances in kinase inhibitor research. Leading researchers will present on hot topics such as reversible and irreversible inhibitors, kinome selectivity and translation, kinase evolution and resistance, and many more. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how kinase inhibitor discovery will continue to expand.

Sessions include:
I. Novel Approaches in Kinase Targeting
II. New Tools and Technologies in Kinase Drug Discovery
III. Kinome Selectivity and Translation to Clinical Safety
IV. Kinase Evolution & Development of Resistance to Kinase Inhibitors

Conference Dates: February 29 - March 1, 2016

https://www.gtcbio.com/conferences/protein-kinases-drug-discovery-overview

6th Ubiquitin Research & Drug Discovery Conference February 29 - March 1, 2016, San Diego, CA ( 8:00 am )

6th Ubiquitin Research & Drug Discovery Conference February 29 - March 1, 2016, San Diego, CA

We are pleased to invite you to GTCbio's 6th Ubiquitin Research & Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered.

Please join us not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas.

Session Topics:

1. Advances in Ubiquitin-like Modifications
2. Ubiquitin Pathways in Neurodegenerative Disorders
3. Ubiquitin Proteasome System & Oncology
4. Autophagy in Cancer & Metabolic Diseases
5. Novel Drug Targets in the Ubiquitin System
6. Deubiquitinating Enzymes as Drug Targets

Conference Dates: February 29 - March 1, 2016

https://www.gtcbio.com/conferences/ubiquitin-research-drug-discovery-overview

Enzymes In Drug Discovery Summit February 29 - March 2, 2016, San Diego, CA ( 8:00 am )

Enzymes in Drug Discovery Summit February 29 - March 2, 2016, San Diego, CA

We are excited to announce the Enzymes in Drug Discovery Summit, which will take place February 29 - March 2, 2016 in San Diego, CA.

Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways to overcome drug resistance to these inhibitors, and discuss breakthroughs in targeting historically undruggable enzymes.

This summit will feature the following four conferences:

11th Protein Kinases in Drug Discovery
I. Novel Approaches in Kinase Targeting
II. New Tools and Technologies in Kinase Drug Discovery
III. Kinome Selectivity and Translation to Clinical Safety
IV. Kinase Evolution & Development of Resistance to Kinase Inhibitors

6th Ubiquitin Research & Drug Discovery

I. Advances in Ubiquitin-like Modifications
II. Ubiquitin Pathways in Neurodegenerative Disorders
III. Ubiquitin Proteasome System & Oncology
IV. Autophagy in Cancer & Metabolic Diseases
V. Epigenetic Novel Drug Targets in the Ubiquitin System
VI. Deubiquitinating Enzymes as Drug Targets

2nd Protease Inhibitors in Drug Discovery

I. Membrane-Associated Systems
II. Medical Chemistry & Drug Design of Protease Inhibitors
III. Non-Active Site Inhibition of Proteases
IV. Protease Inhibitors in Translational Research
- Cardiovascular System
- Infectious Diseases
- Inflammatory Diseases
- Neurodegenerative Diseases
- Musculoskeletal Diseases

Epigenetic Enzymes in Drug Discovery

I. Epigenetic Modification & Transcriptional Regulation
II. Pre-Clinical to Clinical Drug Development
III. Immunotherapy: Conversion of Mechanisms
IV. Translating & Combining Antibodies
V. Novel Therapeutic Targets and Discovery

We encourage you to sign up for a summit pass in order to get the most comprehensive look at research and drug discovery happening in the field. In addition to scientific presentations, dedicated networking sessions will allow you to connect and form new relationships with different people in the field and from both the private and public sector.

We hope to see you there!

Conference Dates: February 29 - March 2, 2016

https://www.gtcbio.com/conferences/enzymes-drug-discovery-summit-overview

Enzymes In Drug Discovery Summit February 29 - March 2, 2016, San Diego, CA ( 8:00 am )

Enzymes in Drug Discovery Summit February 29 - March 2, 2016, San Diego, CA

We are excited to announce the Enzymes in Drug Discovery Summit, which will take place February 29 - March 2, 2016 in San Diego, CA.

Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways to overcome drug resistance to these inhibitors, and discuss breakthroughs in targeting historically undruggable enzymes.

This summit will feature the following four conferences:

11th Protein Kinases in Drug Discovery
I. Novel Approaches in Kinase Targeting
II. New Tools and Technologies in Kinase Drug Discovery
III. Kinome Selectivity and Translation to Clinical Safety
IV. Kinase Evolution & Development of Resistance to Kinase Inhibitors

6th Ubiquitin Research & Drug Discovery

I. Advances in Ubiquitin-like Modifications
II. Ubiquitin Pathways in Neurodegenerative Disorders
III. Ubiquitin Proteasome System & Oncology
IV. Autophagy in Cancer & Metabolic Diseases
V. Epigenetic Novel Drug Targets in the Ubiquitin System
VI. Deubiquitinating Enzymes as Drug Targets

2nd Protease Inhibitors in Drug Discovery

I. Membrane-Associated Systems
II. Medical Chemistry & Drug Design of Protease Inhibitors
III. Non-Active Site Inhibition of Proteases
IV. Protease Inhibitors in Translational Research
- Cardiovascular System
- Infectious Diseases
- Inflammatory Diseases
- Neurodegenerative Diseases
- Musculoskeletal Diseases

Epigenetic Enzymes in Drug Discovery

I. Epigenetic Modification & Transcriptional Regulation
II. Pre-Clinical to Clinical Drug Development
III. Immunotherapy: Conversion of Mechanisms
IV. Translating & Combining Antibodies
V. Novel Therapeutic Targets and Discovery

We encourage you to sign up for a summit pass in order to get the most comprehensive look at research and drug discovery happening in the field. In addition to scientific presentations, dedicated networking sessions will allow you to connect and form new relationships with different people in the field and from both the private and public sector.

We hope to see you there!

Conference Dates: February 29 - March 2, 2016

https://www.gtcbio.com/conferences/enzymes-drug-discovery-summit-overview

Mastering Clinical Trial Documents 16th March 2016, London, United Kingdom ( 8:00 am )

Mastering Clinical Trial Documents 16th March 2016, London, United Kingdom

SMi is proud to announce the return of the 2nd annual Clinical Trial Documentation Management masterclass in 2016!

Good records management not only has an impact on how effectively an organisation manages its records during the conduct of a clinical study; well-managed clinical study records are critical to demonstrating compliance with GCP and other applicable regulations, as well as supporting regulatory inspections.

Once a clinical study is completed, the clinical study records are the primary - and often the only - evidence of clinical study activities, which are critical to permitting evaluation of the conduct of the study and the quality of the data produced.

Through interactive discussions and group activities, this full-day master-class will outline

• Regulations relating to Trial Master File, including best practice guidance and the latest thinking from legislators and regulators
• How clinical study records can be created and managed in both the immediate- and long-term to ensure the timely availability of an inspection-ready TMF

Url: https://www.smi-online.co.uk/pharmaceuticals/uk/masterclass/mastering-clinical-trial-documents

Paediatric Clinical Trials 16th March To 17th March 2016, London, United Kingdom ( 8:00 am )

Paediatric Clinical Trials  16th March to 17th March 2016, London, United Kingdom

SMi is proud to present the 10th Paediatric Clinical Trials Conference, 16th – 17th March 2016, London. This event will look at the paediatric therapeutic developments, directives and procedures which have been put in place to protect children taking part in clinical trials.

Many treatments of today are the result of past clinical trials. The need for improving strategies in conducting paediatric clinical trials has never been greater. Even if the costs linked trials are not always affordable, pharmaceutical industries continue to expand their research.

A series of interactive conference sessions, roundtables and panel discussion facilitated by leading industry experts will provide executives with useful tools and best practices to develop analgesics in paediatric population, implement a strategy regulatory partnership through collaboration, explore innovations in drug formulation, monitor and audit issues specific to paediatric research and utilize clinical pharmacology to model adult data to paediatrics.

Superbugs & Superdrugs - 16th March To 17th March 2016, London, United Kingdom ( 8:00 am )

Superbugs & Superdrugs - Pushing financial incentives and collaborative incentives to accelerate clinical success on 16th March to 17th March 2016, London, United Kingdom

The threat of antibiotic- resistant microbes poses one of the biggest economic and health threats in our time, as microbes are becoming more resistant and fewer drugs are passing clinical trials successfully.

Moreover, the increase in global migration accelerates the spread as we have seen from Mers and Ebola viruses, as well as overconsumption and hospital acquired infections.

Thus, our 18th year in hosting Superbugs and Superdrugs continues to address the core challenges in the industry from: Investment, R&D to hospital hygiene, and consumer engagement and review current strategies.

We’re now seeing strong leaderships and collaborations to fund research and investment from the likes of: The Welcome Trust, IMI, and BARDA who are invited to share their funding strategies to strengthen the antiobiotics pipeline.

Url: https://www.smi-online.co.uk/pharmaceuticals/uk/conference/superbugs-superdrugs

Paediatric Clinical Trials 16th March To 17th March 2016, London, United Kingdom ( 8:00 am )

Paediatric Clinical Trials  16th March to 17th March 2016, London, United Kingdom

SMi is proud to present the 10th Paediatric Clinical Trials Conference, 16th – 17th March 2016, London. This event will look at the paediatric therapeutic developments, directives and procedures which have been put in place to protect children taking part in clinical trials.

Many treatments of today are the result of past clinical trials. The need for improving strategies in conducting paediatric clinical trials has never been greater. Even if the costs linked trials are not always affordable, pharmaceutical industries continue to expand their research.

A series of interactive conference sessions, roundtables and panel discussion facilitated by leading industry experts will provide executives with useful tools and best practices to develop analgesics in paediatric population, implement a strategy regulatory partnership through collaboration, explore innovations in drug formulation, monitor and audit issues specific to paediatric research and utilize clinical pharmacology to model adult data to paediatrics.

Superbugs & Superdrugs - 16th March To 17th March 2016, London, United Kingdom ( 8:00 am )

Superbugs & Superdrugs - Pushing financial incentives and collaborative incentives to accelerate clinical success on 16th March to 17th March 2016, London, United Kingdom

The threat of antibiotic- resistant microbes poses one of the biggest economic and health threats in our time, as microbes are becoming more resistant and fewer drugs are passing clinical trials successfully.

Moreover, the increase in global migration accelerates the spread as we have seen from Mers and Ebola viruses, as well as overconsumption and hospital acquired infections.

Thus, our 18th year in hosting Superbugs and Superdrugs continues to address the core challenges in the industry from: Investment, R&D to hospital hygiene, and consumer engagement and review current strategies.

We’re now seeing strong leaderships and collaborations to fund research and investment from the likes of: The Welcome Trust, IMI, and BARDA who are invited to share their funding strategies to strengthen the antiobiotics pipeline.

Url: https://www.smi-online.co.uk/pharmaceuticals/uk/conference/superbugs-superdrugs

8th Ocular Diseases Drug Discovery Conference March 21-22, 2016, San Diego, CA ( 8:00 am )

The 8th Ocular Diseases Drug Discovery Conference is taking place on March 21-22, 2016 in San Diego, CA. Novel therapeutics from the nanotechnology scope are on the rise. The progress in drug and gene-loaded particles that adequately pass through the mucus barriers provides better delivery to ocular tissue. Recent developments in gene therapies with sustained release of a protein have shown promising results with lesser side effects in patients.

We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), and other ocular diseases. Other hot topics include PRINT® platform for intraocular prostaglandin formulation, coating technology, anti-angiogenic mechanisms and much more!

Url: https://www.gtcbio.com/conferences/ocular-diseases-drug-discovery-overview

8th Ocular Diseases Drug Discovery Conference March 21-22, 2016, San Diego, CA ( 8:00 am )

The 8th Ocular Diseases Drug Discovery Conference is taking place on March 21-22, 2016 in San Diego, CA. Novel therapeutics from the nanotechnology scope are on the rise. The progress in drug and gene-loaded particles that adequately pass through the mucus barriers provides better delivery to ocular tissue. Recent developments in gene therapies with sustained release of a protein have shown promising results with lesser side effects in patients.

We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), and other ocular diseases. Other hot topics include PRINT® platform for intraocular prostaglandin formulation, coating technology, anti-angiogenic mechanisms and much more!

Url: https://www.gtcbio.com/conferences/ocular-diseases-drug-discovery-overview

Academic Drug Discovery 2016 March 22-23 2016 Cambridge, UK ( 8:00 am )

Academic Drug Discovery 2016 March 22-23  2016 Cambridge, UK

SELECTBIO is pleased to announce Academic Drug Discovery 2016, which will be held on 22 - 23 March 2016 in Cambridge, UK. The event is part of our Cambridge Workshop Series. 

Attracting a global audience of researchers, academics, group leaders, directors and the global heads of leading academic and open innovation drug discovery centres, this event will explore the current challenges and opportunities faced in academic drug discovery. 

In recent years pharmaceutical companies have moved away from conducting early-stage preclinical research in-house and are instead partnering with academic institutions to pursue programmes around emerging targets. This has resulted in significant opportunities for academic-based drug discovery and development centres. 

If you work in drug discovery research you will benefit from the expert knowledge and insights provided by academic and industry leaders who are successfully demonstrating models of collaborative drug discovery.

Url: https://selectbiosciences.com/conferences/index.aspx?conf=ADD2016

Containment Of Highly Potent API’s 22nd March 2016, London, United Kingdom ( 8:00 am )

Containment of Highly Potent API’s  22nd March 2016, London, United Kingdom

SMi is proud to announce the return of the 2nd annual Containment of Highly Potent API’s masterclass in 2016!

A shift in recent years toward the use of highly potent active pharmaceutical ingredients (HPAPIs) has led to a significant change in the way innovators are using small molecules to deliver patient therapies. With this change comes the requirement of significant planning, proper equipment, and facility design as well as implementation of the necessary procedures to safely handle HPAPI’s.

This masterclass on containment provides all relevant information in terms of how to produce highly potent or highly hazardous pharmaceutical products. The case study on a risk assessment will provide the audience the tool on how to perform a risk assessment by themselves. Technical containment solutions together with their performance on the OSD or API process equipment will offer the audience an overview of what is on the market with detailed technical information. A containment case study based on the ISPE SMEPAC Good
Practice Guide will round up the masterclass.

Url: https://www.smi-online.co.uk/pharmaceuticals/uk/masterclass/containment-of-highly-potent-apis

Academic Drug Discovery 2016 March 22-23 2016 Cambridge, UK ( 8:00 am )

Academic Drug Discovery 2016 March 22-23  2016 Cambridge, UK

SELECTBIO is pleased to announce Academic Drug Discovery 2016, which will be held on 22 - 23 March 2016 in Cambridge, UK. The event is part of our Cambridge Workshop Series. 

Attracting a global audience of researchers, academics, group leaders, directors and the global heads of leading academic and open innovation drug discovery centres, this event will explore the current challenges and opportunities faced in academic drug discovery. 

In recent years pharmaceutical companies have moved away from conducting early-stage preclinical research in-house and are instead partnering with academic institutions to pursue programmes around emerging targets. This has resulted in significant opportunities for academic-based drug discovery and development centres. 

If you work in drug discovery research you will benefit from the expert knowledge and insights provided by academic and industry leaders who are successfully demonstrating models of collaborative drug discovery.

Url: https://selectbiosciences.com/conferences/index.aspx?conf=ADD2016

11th Protein Kinases In Drug Discovery Conference February 29 - March 1, 2016, San Diego, CA ( 8:00 am )

11th Protein Kinases in Drug Discovery Conference February 29 - March 1, 2016, San Diego, CA

We invite you to attend the 11th Protein Kinases in Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA.

Over the past decades, protein kinases have proven to be an important class of drug targets for the pharmaceutical industry. This meeting seeks to create a forum for scientists from both industry and academia to gather and discuss the most recent advances in kinase inhibitor research. Leading researchers will present on hot topics such as reversible and irreversible inhibitors, kinome selectivity and translation, kinase evolution and resistance, and many more. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how kinase inhibitor discovery will continue to expand.

Sessions include:
I. Novel Approaches in Kinase Targeting
II. New Tools and Technologies in Kinase Drug Discovery
III. Kinome Selectivity and Translation to Clinical Safety
IV. Kinase Evolution & Development of Resistance to Kinase Inhibitors

Conference Dates: February 29 - March 1, 2016

https://www.gtcbio.com/conferences/protein-kinases-drug-discovery-overview

6th Ubiquitin Research & Drug Discovery Conference February 29 - March 1, 2016, San Diego, CA ( 8:00 am )

6th Ubiquitin Research & Drug Discovery Conference February 29 - March 1, 2016, San Diego, CA

We are pleased to invite you to GTCbio's 6th Ubiquitin Research & Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered.

Please join us not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas.

Session Topics:

1. Advances in Ubiquitin-like Modifications
2. Ubiquitin Pathways in Neurodegenerative Disorders
3. Ubiquitin Proteasome System & Oncology
4. Autophagy in Cancer & Metabolic Diseases
5. Novel Drug Targets in the Ubiquitin System
6. Deubiquitinating Enzymes as Drug Targets

Conference Dates: February 29 - March 1, 2016

https://www.gtcbio.com/conferences/ubiquitin-research-drug-discovery-overview

Enzymes In Drug Discovery Summit February 29 - March 2, 2016, San Diego, CA ( 8:00 am )

Enzymes in Drug Discovery Summit February 29 - March 2, 2016, San Diego, CA

We are excited to announce the Enzymes in Drug Discovery Summit, which will take place February 29 - March 2, 2016 in San Diego, CA.

Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways to overcome drug resistance to these inhibitors, and discuss breakthroughs in targeting historically undruggable enzymes.

This summit will feature the following four conferences:

11th Protein Kinases in Drug Discovery
I. Novel Approaches in Kinase Targeting
II. New Tools and Technologies in Kinase Drug Discovery
III. Kinome Selectivity and Translation to Clinical Safety
IV. Kinase Evolution & Development of Resistance to Kinase Inhibitors

6th Ubiquitin Research & Drug Discovery

I. Advances in Ubiquitin-like Modifications
II. Ubiquitin Pathways in Neurodegenerative Disorders
III. Ubiquitin Proteasome System & Oncology
IV. Autophagy in Cancer & Metabolic Diseases
V. Epigenetic Novel Drug Targets in the Ubiquitin System
VI. Deubiquitinating Enzymes as Drug Targets

2nd Protease Inhibitors in Drug Discovery

I. Membrane-Associated Systems
II. Medical Chemistry & Drug Design of Protease Inhibitors
III. Non-Active Site Inhibition of Proteases
IV. Protease Inhibitors in Translational Research
- Cardiovascular System
- Infectious Diseases
- Inflammatory Diseases
- Neurodegenerative Diseases
- Musculoskeletal Diseases

Epigenetic Enzymes in Drug Discovery

I. Epigenetic Modification & Transcriptional Regulation
II. Pre-Clinical to Clinical Drug Development
III. Immunotherapy: Conversion of Mechanisms
IV. Translating & Combining Antibodies
V. Novel Therapeutic Targets and Discovery

We encourage you to sign up for a summit pass in order to get the most comprehensive look at research and drug discovery happening in the field. In addition to scientific presentations, dedicated networking sessions will allow you to connect and form new relationships with different people in the field and from both the private and public sector.

We hope to see you there!

Conference Dates: February 29 - March 2, 2016

https://www.gtcbio.com/conferences/enzymes-drug-discovery-summit-overview